Results 81 to 90 of about 1,602 (208)

Appetite and dietary intake endpoints in cancer cachexia clinical trials: Systematic Review 2 of the cachexia endpoints series

open access: yesJournal of Cachexia, Sarcopenia and Muscle, Volume 15, Issue 2, Page 513-535, April 2024.
Abstract There is no consensus on the optimal endpoint(s) in cancer cachexia trials. Endpoint variation is an obstacle when comparing interventions and their clinical value. The aim of this systematic review was to summarize and evaluate endpoints used to assess appetite and dietary intake in cancer cachexia clinical trials.
Ola Magne Vagnildhaug   +24 more
wiley   +1 more source

Медикаментозное управление окислительно-восстановительным состоянием организма при заболеваниях органов дыхания (часть 3) [PDF]

open access: yes, 2018
В огляді літератури наведено сучасні дані щодо групи антиоксидантних лікарських засобів — сполук, що містять тіол. Показано їх дію на окислювально-відновний статус організму при захворюваннях органів дихання.
Абатуров, А.Е.   +2 more
core  

Loading of beclomethasone in liposomes and hyalurosomes improved with mucin as effective approach to counteract the oxidative stress generated by cigarette smoke extract [PDF]

open access: yes, 2021
In this work beclomethasone dipropionate was loaded into liposomes and hyalurosomes modified with mucin to improve the ability of the payload to counteract the oxidative stress and involved damages caused by cigarette smoke in the airway.
Di Vincenzo S.   +7 more
core   +1 more source

Evaluation of the Effects of a Cosmetic Cream on Irritant Contact Dermatitis: Results of a Multicentre Open Trial

open access: yesEuropean Journal of Inflammation, 2003
The symptoms of irritant contact dermatitis (ICD) are often controlled by topical corticosteroids, which, however, are not suitable for the long-term management owing to the risk of side effects.
N. Cassano   +17 more
doaj   +1 more source

Effect of Penetration Enhancers on Drug Nail Permeability from Cyclodextrin/Poloxamer-Soluble Polypseudorotaxane-Based Nail Lacquers

open access: yesPharmaceutics, 2018
Nail delivery has interest for local treatment of nail diseases. Nevertheless, the low permeability of drugs in the nail plaque precludes the efficacy of local treatments.
Elena Cutrín-Gómez   +4 more
doaj   +1 more source

Лікування ракової кахексії [PDF]

open access: yes, 2012
В лікуванні ракової кахексії надають значення нутрітивній терапії, введенню анаболічних гормонів, мегестролу-ацетату, оріксігенних засобів.
Бабін, Володимир Дмитрович   +4 more
core  

Concomitant therapy with Cineole (Eucalyptole) reduces exacerbations in COPD: A placebo-controlled double-blind trial [PDF]

open access: yes, 2009
This is an Open Access article distributed under the terms of the Creative Commons Attribution ...
DE Niewoehner   +20 more
core   +4 more sources

Determining % Proliss 100 in Keratin Mousse Using Iodine Solution Method [PDF]

open access: yes, 2015
The objective of this experiment is to quantitatively determine the amount of active raw material Proliss 100 manufactured and supplied by a formulation company. The goal is to reproduce the percent of Proliss in Keratin Mousse production sample provided
Moore, Quiana
core   +1 more source

Spectrophotometric study of the charge transfer complexation of some amino acid derivative drugs as electron donors with 7,7,8,8-tetracyanoquinodimethane

open access: yesBulletin of the Chemical Society of Ethiopia, 2010
Charge transfer (CT) complexes of some drugs of amino acid derivatives, such as carbocysteine, aminobutyric acid, and levodopa, as electron donors with 7,7,8,8-tetracyanoquinodimethane (TCNQ) as electron acceptor have been studied.
Sheng Yun Li   +4 more
doaj  

Phosphodiesterase 3 inhibition and cough in elderly asthmatics [PDF]

open access: yes, 2005
AIMS: Cough is a common symptom of bronchial asthma, a chronic inflammatory airway disease. Recently, the therapeutic effects of selective phosphodiesterase (PDE) inhibitors have been focused on bronchial asthma.
Abo, Miki   +6 more
core   +3 more sources

Home - About - Disclaimer - Privacy